Table 2.
Basic characteristics of studied subjects with PCOS
| Variables | Intervention (n = 99) |
Placebo (n = 95) |
P* |
|---|---|---|---|
| Age, year | 32.99 ± 5.57* | 33.81 ± 5.42 | 0.073 |
| Total MET, MET min/week | 351.39 ± 502.01 | 294.76 ± 456.84 | 0.271 |
| Marital status, married % | 85.9 | 82.1 | 0.303 |
| Anthropometric indices | |||
| Weight, kg | 86.26 ± 10 | 87.38 ± 10.75 | 0.506 |
| WC, cm | 113.01 ± 12.55 | 113.57 ± 7.89 | 0.683 |
| BMI, kg/m2 | 34.78 ± 3.39 | 35.18 ± 5.16 | 0.989 |
| Body fat, % | 46.12 ± 2.72 | 47.13 ± 3.11 | 0.151 |
| Biochemical indices | |||
| FBS, mg/dl | 106.2 ± 11.88 | 104.88 ± 10.87 | 0.33 |
| HbA1C, % | 6.78 ± 2.26 | 6.97 ± 2.12 | 0.425 |
| Insulin, μU/ml | 27.12 ± 3.92 | 26.02 ± 5.14 | 0.06 |
| HOMA-IR | 7.09 ± 1.28 | 6.72 ± 1.41 | 0.617 |
| Leptin, ng/ml | 28.62 ± 9.35 | 30.71 ± 8.45 | 0.324 |
| TSH, μIU/mL | 2.86 ± 0.24 | 2.89 ± 0.25 | 0.704 |
| Gerlin, pmol/l | 0.42 ± 0.03 | 0.39 ± 0.04 | < 0.001 |
| Androstenedione, ng/ml | 2.09 ± 1.81 | 1.97 ± 0.32 | 0.121 |
| DHEA, ng/dL | 321.27 ± 62.38 | 363.39 ± 76.01 | 0.198 |
| Prolactin, ng/ml | 8.44 ± 4.22 | 7.78 ± 4.09 | 0.647 |
| Testosterone, ng/ml | 1.24 ± 0.21 | 1.35 ± 0.21 | 0.99 |
| LH, IU/L | 6.31 ± 1.41 | 5.94 ± 2.28 | < 0.001 |
| FSH, IU/L | 1.82 ± 0.74 | 1.32 ± 0.84 | 0.283 |
| SHBG, nm/l | 27.77 ± 10.63 | 33.12 ± 10.17 | 0.726 |
| 25 (OH) D3, ng/mL | 20.03 ± 11.23 | 18.7 ± 11.26 | 0.371 |
*Mean ± SD
P* was obtained chi-square, Mann–Whitney U, and independent sample t test